Just 30 of the 166 new drugs approved for marketing in Canada between 2018 and 2022 had ended up on public drug formularies by the end of 2023, CHPI reported. In the United States, 241 new drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback